An innovative organoid model mirrors the pancreas' complexity, generating all three key cell types to explore development and ...

Pancreatic cancer is one of the deadliest types of cancer, with very few people surviving for more than five years after ...

These tests are used to not only diagnose carcinomas but also to stage and grade the ... Basal cell carcinoma, for example, has a five-year survival rate of 100%. Pancreatic ductal adenocarcinoma ...

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy characterized by distinct histological subtypes and a poor prognosis. Among these, the micropapillary pattern, typically observed ...

The scientists discovered that low-grade pancreatic cancer cells ... A mucus production programme promotes classical ...

The addition of high-dose IV vitamin C to standard chemotherapy nearly doubled OS for patients with advanced pancreatic ...

This discovery is exciting because it opens up a new way to fight pancreatic cancer. If doctors can develop treatments that ...

Most of these lesions are benign or slow growing and the prognosis is significantly better than with pancreatic adenocarcinoma. However, some of these neoplasms slowly undergo malignant transformation ...

Pelareorep plus chemotherapy with or without Tecentriq had an acceptable safety profile in patients with newly diagnosed ...

Pancreatic cancer is a disease in which malignant cells originate in the pancreatic tissue. Cancer of the exocrine component of the pancreas (adenocarcinomas) represents the majority of pancreatic ...